drugset / Trial / NCT00308503

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

NCT00308503

Phase 3 Completed 608 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to confirm the efficacy of eplivanserin 5mg/day on sleep maintenance of patients with primary insomnia using night polysomnography recordings over a 6-week treatment period corresponding to a stabilization of improvement of sleep.

Timeline

Start
2006-02
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject eplivanserin Small molecule 5 mg Oral